SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1213141516171819Next Page
2026-05-29BCLI4Jacob A. Frenkel Buys 200,000 Shares of Common StockMEDIUM
On February 26, 2026, Jacob A. Frenkel, a director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), acquired 200,000 shares of common stock through the award of restricted stock units (RSUs). These RSUs were granted under the company's 2014 Global Share Option Plan. The award vests such that 50% vests immediately on the gr...
Biotechnologyacquired_a
2026-05-29EXEL4Form 4 Filing for Exelixis, Inc. - Insider TransactionMEDIUM
Maria C. Freire, a director at Exelixis, Inc., acquired 8,367 shares of common stock on May 27, 2026, through the vesting of restricted stock units (RSUs) granted under the company's 2017 Equity Incentive Plan. These RSUs, granted on the transaction date, are the economic equivalent of common stock and will fully vest ...
Large CapBiotechnologyacquired_a
Previous Page1213141516171819Next Page